The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.
Although there is considerable evidence about the efficacy of artemisinin-based combination therapy (ACTs), there is little evidence on how best to deploy this WHO-recommended treatment.
Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality.
The ACT Consortium is funded by the Bill and Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States. It is coordinated through the London School of Hygiene and Tropical Medicine.